These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19066962)

  • 1. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
    Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.
    Zhuang PY; Shen J; Zhu XD; Lu L; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(5):e64598. PubMed ID: 23737988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
    Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
    Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy.
    Zhuang PY; Wang JD; Tang ZH; Zhou XP; Yang Y; Quan ZW; Liu YB; Shen J
    Oncotarget; 2014 Nov; 5(22):11121-32. PubMed ID: 25333267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
    von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
    Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Holm R; Giercksky KE; Nesland JM
    Histopathology; 2012 Sep; 61(3):350-64. PubMed ID: 22690749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
    Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
    Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].
    Dales JP; Garcia S; Bonnier P; Duffaud F; Carpentier S; Djemli A; Ramuz O; Andrac L; Lavaut M; Allasia C; Charpin C
    Ann Pathol; 2003 Sep; 23(4):297-305. PubMed ID: 14597894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
    Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
    Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
    Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
    World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
    Vizio B; Bosco O; David E; Caviglia GP; Abate ML; Schiavello M; Pucci A; Smedile A; Paraluppi G; Romagnoli R; Lupia E; Bellone G; Montrucchio G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression and significance of vascular endothelial growth factor and its receptors in hepatocellular carcinoma cell lines with various metastatic potentialities].
    Ai JH; Zheng SG; Zeng YY; Xiong Y; Zhang LD; Dong JH
    Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):105-8. PubMed ID: 18304425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders.
    Marini M; Vichi D; Toscano A; Zappoli Thyrion GD; Parretti E; Mello G; Gheri G; Pacini A; Sgambati E
    Reprod Fertil Dev; 2007; 19(5):641-51. PubMed ID: 17601412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.